Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. [electronic resource]
Producer: 20070402Description: 573-80 p. digitalISSN:- 0278-2391
- Aged
- Alendronate -- adverse effects
- Bone Density Conservation Agents -- administration & dosage
- Clinical Protocols
- Female
- Humans
- Injections, Subcutaneous
- Mandibular Diseases -- chemically induced
- Osteonecrosis -- chemically induced
- Teriparatide -- administration & dosage
- Tooth Extraction -- adverse effects
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.